Navigation

Head and neck cancer - cetuximab

Cetuximab for the treatment of head and neck cancer

Status: History
Expected date of issue: June 2008
Process: STA
Topic area:
  • Cancer
 

NICE project team

Executive Lead: Peter Littlejohns
Technical Lead: Nicola Hay
Communications manager: Sarita Tamber
Project manager: Christopher Feinmann
Assessment Group / Evidence Review Group: Centre for Health Economics, University of York and the Regional Drug and Therapeutics Centre, Newcastle
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 02 August 2006
1st appraisal committee meeting: 09 November 2006
2nd appraisal committee meeting 11 January 2007
3rd appraisal committee meeting: 15 March 2007
4th appraisal committee meeting: 16 January 2008
5th appraisal committee meeting: 12 March 2008
Schedule comments: A 3rd appraisal committee meeting may be held subject to consultation on ACD.
Top


 

Consultees and commentators

Consultees Commentators (no right of appeal)

Manufacturers / Sponsors

  • Merck Pharmaceuticals UK
  • Patient / Carer Groups
  • Cancerbackup
  • Get A-Head
  • Let's Face It
  • Mouth Cancer Foundation
  • National Association Of Laryngectomee Clubs

Professional Groups

  • British Association of Head and Neck Oncologists
  • British Association of Head and Neck Oncology Nurses
  • British Association of Oral and Maxillofacial Surgeons
  • Cancer Networks Pharmacists forum (BOPA)
  • Cancer Research UK
  • Royal College of General Practitioners
  • Royal College of Nursing
  • Royal College of Paediatrics and Child Health
  • Royal College of Pathologists
  • Royal College of Physicians' Medical Oncology Joint Special Committee
  • Royal College of Radiologists
  • Royal Pharmaceutical Society
  • Welsh Association of Head and Neck Oncologists

Others

  • Department of Health
  • Sheffield South West PCT
  • Welsh Assembly Government

General

  • British National Formulary
  • Department of Health, Social Services and Public Safety for Northern Ireland
  • NHS Quality Improvement Scotland

Comparator Manufacturers

  • None
  • Evidence Review Groups
  • Centre for Health Economics, University of York and the Regional Drug and Therapeutics Centre, Newcastle
  • National Coordinating Centre for Health Technology Assessment

Associated Guideline Groups

  • National Collaborating Centre for Cancer

Associated Public Health Groups

  • None

Research Groups

  • King's College Hospital Maxillofacial Unit - The Head and Neck Oncology Group
  • MRC Clinical Trials Unit

Top


 

Project history

Date Update
16 August 2004 Topic summary published
26 January 2005 Project Manager updated
10 June 2005 Schedule updated
27 April 2006 Topic transferred to Single Technology Appraisal (STA) process; schedule updated accordingly.
9 June 2006 Project team, provisional schedule and stakeholders updated.
7 August 2006 Stakeholders updated.
24 November 2006 Stakeholders updated.
27 November 2006 Update letter to consultees and commentators added,
15 December 2006 Schedule and project team updated,
11 January 2008 Schedule updated,
11 January 2008 Stakeholders updated,
Top


 

Key documents

This page was last updated: 30 March 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.